Tamboran Resources Corp: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 14, 2025 and accepted by EDGAR at May 13, 2025, 19:09 ET.
Management's discussion and analysis
As filed, 23,384 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our
condensed consolidated financial statements, the accompanying notes to the condensed consolidated financial statements
and other financial information included in this report and in our Annual Report on Form 10-K for the year ended June 30,
2024. For further information on items that could impact our financial condition and operating performance, see the section
entitled “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended June 30, 2024, and “Cautionary Note
Regarding Forward-Looking Statements” in this report.
The following tables present selected financial information for the periods presented (dollar amounts in
thousands):
| Three months ended March 31, 2025 | 2024 | Nine months ended March 31, 2025 | 2024 | |
|---|---|---|---|---|
| Revenue and other operating income | $— | $— | $— | $— |
| Operating costs and expenses: | ||||
| Compensation and benefits, including stock-based compensation | (2,430) | (1,938) | (6,333) | (3,703) |
| Consultancy, legal and professional fees | (1,420) | (1,078) | (4,104) | (4,863) |
| Depreciation and amortization | (23) | (32) | (85) | (90) |
| Loss on remeasurement of assets classified as held for sale | — | — | (376) | (26) |
| Accretion of asset retirement obligations | (275) | (231) | (774) | (661) |
| Exploration expense | (1,201) | 423 | (3,684) | (2,964) |
| LNG feasibility study expense | (1,978) | — | (5,211) | — |
| Checkerboard fee | — | — | (5,950) | — |
| General and administrative | (1,474) | (704) | (4,278) | (2,302) |
| Total operating costs and expenses | (8,801) | (3,560) | (30,795) | (14,609) |
| Other income (expense): | ||||
| Interest income, net | 51 | 255 | 1,553 | 503 |
| Foreign exchange loss, net | 142 | 659 | (1,340) | 385 |
| Other income (expense), net | 435 | (1) | 153 | (200) |
| Total other income (expense) | 628 | 913 | 366 | 688 |
| Net loss | (8,173) | (2,647) | (30,429) | (13,921) |
| Foreign currency translation | 1,477 | (12,199) | (15,532) | (3,866) |
| Total comprehensive income (loss) attributable to noncontrolling interest | (943) | (1,300) | (5,735) | (1,956) |
| Total comprehensive income (loss) attributable to Tamboran Resources stockholders | $(5,753) | $(13,546) | $(40,226) | $(15,831) |
30
Results of Operations for the Three Months Ended March 31, 2025 and 2024
Revenue and other operating income. We have not yet commenced natural gas production; therefore, we did not
earn any revenue and other operating income during the three months ended March 31, 2025 and 2024, respectively.
Compensation and benefits, including stock-based compensation. Compensation and benefits, including stock-
based compensation, increased by $0.5 million during the three months ended March 31, 2025, as compared to the three
months ended March 31, 2024, due primarily to restricted stock units granted in August 2024 and increased headcount as
compared to the comparative period, while the prior period reflected performance-based bonuses issued during the period.
Consultancy, legal and professional fees. Consultancy, legal and professional fees increased by $0.3 million
during the three months ended March 31, 2025, as compared to the three months ended March 31, 2024, as a majority of
the legal fees incurred during the comparative period were deferred to stock issuance costs within the condensed
consolidated balance sheet, reducing the portion of costs expensed. Other legal, consultancy and professional fees remained
fairly consistent during the three months ended March 31, 2025.
Accretion of asset retirement obligations expense. For the three months ended March 31, 2025, an expense for
accretion of asset retirement obligations of $0.3 million was recognized. The recognition of such an expense was due to the
accretion of asset retirement obligation liabilities in relation to all EPs, inclusive of EPs 76, 98, 117, 136 and 161, as well
as the SPCF pad.
Exploration expense. For the three months ended March 31, 2025, an expense for exploration of $1.2 million
expense was recognized related to topographical, geographical and geophysical studies.
LNG feasibility study expense. During the three months ended March 31, 2025, the Group incurred expenses of
$2.0 million related to certain studies and pre-front-end engineering and design services related to the proposed NT LNG
facility.
General and administrative. General and administrative costs increased by $0.8 million during the three months
ended March 31, 2025, as compared to the three months ended March 31, 2024, primarily as a result of increased expenses
related to headcount, travel, insurance, and office and administrative fees.
Interest income, net. Interest income, net decreased by $0.2 million during the three months ended March 31,
2025, as compared to the three months ended March 31, 2024, primarily due to interest received from term deposits using
IPO proceeds during the period ended March 31, 2024 which did not exist during the comparative period.
Foreign currency translation. For the three months ended March 31, 2025, we recognized a foreign currency
translation gain of $1.5 million, primarily due to the strengthening of the Australian Dollar as of March 31, 2025, as
compared to December 31, 2024. In the three months ended March 31, 2024, we recognized a foreign currency translation
loss of $12.2 million, primarily due to the weakening of the Australian Dollar as of March 31, 2024, as compared to
December 31, 2023. Foreign exchange gains and losses resulting from the settlement of foreign currency transactions and
from the translation at fiscal year-end exchange rates of monetary assets and liabilities denominated in foreign currencies
are recognized on our condensed consolidated statement of operations and comprehensive loss.
Income tax expense. We have no income tax expense due to operating losses incurred for the three months ended
March 31, 2025, and 2024. We have provided a full valuation allowance on our net deferred tax asset because management
has determined that it is more likely than not that we will not earn income sufficient to realize the deferred tax assets during
a foreseeable future period. Management will continue to assess the potential for realizing deferred tax assets based upon
income forecast data and the feasibility of future tax planning strategies and may record adjustments to the valuation
allowance against deferred tax assets in future periods, as appropriate, that could have a material impact on the condensed
consolidated statement of operations and comprehensive loss.
31
Result of Operations for the Nine Months Ended March 31, 2025 and 2024
Revenue and other operating income. We have not yet commenced natural gas production; therefore, we did not
earn any revenue and other operating income during the nine months ended March 31, 2025 and 2024, respectively.
Compensation and benefits, including stock-based compensation. Compensation and benefits, including stock-
based compensation, increased by $2.6 million during the nine months ended March 31, 2025, as compared to the nine
months ended March 31, 2024, due primarily to the restricted stock units granted in August 2024 and increased headcount
as compared to the comparative period.
Consultancy, legal and professional fees. Consultancy, legal and professional fees decreased by $0.8 million
during the nine months ended March 31, 2025, as compared to the nine months ended March 31, 2024, primarily due to
professional fees related to implementation of the scheme of arrangement and IPO readiness incurred in the comparative
period in 2024 which did not recur in the nine months ended March 31, 2025.
Loss on remeasurement of assets classified as held for sale. The Group recognized a loss on assets classified as
held for sale amounting to $0.4 million during the nine months ended March 31, 2025, due to the write down of rig 403 to
the fair value less costs to sell. In contrast, a loss on assets classified as held for sale amounting to $0.03 million was
recognized during the nine months ended March 31, 2024, due to the sale of a smaller rig, rig 301.
Accretion of asset retirement obligations expense. For the nine months ended March 31, 2025, an expense for
accretion of asset retirement obligations of $0.8 million was recognized. The recognition of such an expense was due to the
accretion of asset retirement obligation liabilities in relation to all EPs, inclusive of EPs 76, 98, 117, 136 and 161, as well
as SPCF for the new well and related well pads drilled during the period. As the Group drilled two additional wells and
established the SPCF site during the nine months ended March 31, 2025, the expense for the current period has increased
marginally from that of the comparative period.
Exploration expense. Exploration expense increased by $0.7 million during the nine months ended March 31,
2025, as compared to nine months ended March 31, 2024, primarily due to increased activity for topographical,
geographical and geophysical studies and other indirect expenditure relating to the non-operated joint venture in the current
period.
LNG feasibility study expense. During the nine months ended March 31, 2025, the Group incurred expenses of
$5.2 million related to certain studies and pre-front-end engineering and design services related to the proposed NT LNG
facility.
Checkerboard fee. During the nine months ended March 31, 2025, the Group incurred an expense of $6.0 million
related to the satisfaction of certain payment obligations to DWE under the TB1 Joint Venture Agreement. This obligation
was satisfied through the issuance of common stock, subsequent to shareholder approval received in November 2024.
General and administrative. General and administrative costs increased by $2.0 million during the nine months
ended March 31, 2025, as compared to the nine months ended March 31, 2024, primarily as a result of increased expenses
related to insurance, headcount, travel, and other office and administrative fees.
Interest income, net. Interest income, net increased by $1.1 million during the nine months ended March 31, 2025,
as compared to the nine months ended March 31, 2024, primarily due to interest received from term deposits using IPO
proceeds during the period ended March 31, 2025, which did not exist during the comparative period.
Foreign currency translation. For the nine months ended March 31, 2025, we recognized a foreign currency
translation loss of $15.5 million, primarily due to the weakening of the Australian Dollar as of March 31, 2025, as
compared to July 1, 2024. In the nine months ended March 31, 2024, we recognized a foreign currency translation loss of
$3.9 million, primarily due to the weakening of the Australian Dollar as of March 31, 2024, as compared to July 1, 2023.
Foreign exchange gains and losses resulting from the settlement of foreign currency transactions and from the translation at
fiscal year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognized on our
condensed consolidated statement of operations and comprehensive loss.
Income tax expense. We have no income tax expense due to operating losses incurred for the nine months ended
March 31, 2025, and 2024. We have provided a full valuation allowance on our net deferred tax asset because management
32
has determined that it is more likely than not that we will not earn income sufficient to realize the deferred tax assets during
a foreseeable future period. Management will continue to assess the potential for realizing deferred tax assets based upon
income forecast data and the feasibility of future tax planning strategies and may record adjustments to the valuation
allowance against deferred tax assets in future periods, as appropriate, that could have a material impact on the condensed
consolidated statement of operations and comprehensive loss.
33
Liquidity and Capital Resources
We are a development stage enterprise and will continue to be so until commencement of substantial production
from our natural gas properties. We do not expect to generate any revenue from production until late 2026, at the earliest,
which will depend upon successful drilling results, additional and timely capital funding, negotiation of certain commercial
agreements and access to suitable infrastructure. Until then our primary sources of liquidity are expected to be cash on
hand, residual net proceeds from our IPO, and funds from future private and public equity placements, debt funding and
asset sales.
We expect to incur substantial expenses and generate significant operating losses as we continue to develop our
natural gas prospects and as we:
- complete our current appraisal drilling and testing program;
- develop and commercialize our assets, including the SPCF, the proposed NT LNG facility and other
infrastructure;
- opportunistically invest in additional natural gas assets adjacent to our current positions; and
- incur expenses related to operating as a public company and compliance with regulatory requirements.
Our future financial condition and liquidity will be impacted by, among other factors, the success of our
exploration and appraisal drilling program, the number of commercially viable natural gas discoveries made, the quantities
of natural gas discovered, the speed with which we can bring such discoveries to production, and the actual cost of
exploration, appraisal and development of our prospects.
For the remainder of the fiscal year ending June 30, 2025, we estimate that we will need to invest approximately
$13.0 million to progress our development plans. We expect our existing cash on hand to be sufficient to fund our planned
flow testing of SS-2H ST1 and to progress SS-3H. However, we may require significant additional funds earlier than we
currently expect in order to execute our strategy as planned. Additional funding may not be available to us on acceptable
terms or at all. In addition, the terms of any financing may adversely affect the holdings or the rights of our stockholders.
For example, if we raise additional funds by issuing additional equity securities, further dilution to our existing
stockholders will result. If we are unable to obtain funding on a timely basis, we may be required to significantly curtail
one or more of our planned activities. We also could be required to seek funds through arrangements with collaborators or
others that may require us to relinquish rights to some of our assets which we would otherwise develop on our own, or with
a majority working interest.
Cash and Cash Equivalents
The following table summarizes our key measures of liquidity for the periods indicated (in thousands).
| March 31, 2025 | June 30, 2024 | |
|---|---|---|
| Cash and cash equivalents | $25,636 | $74,746 |
As of March 31, 2025, we had $25.6 million of cash and cash equivalents. This balance represents a decrease of
$49.1 million from June 30, 2024, due to incoming funds from the greenshoe option exercised in July 2024, the sale of rig
403 in October 2024, R&D tax credits received in December 2024, and cash calls received throughout the period which are
offset primarily by spending on operations on the SS-2H, SS-2H side track, and SS-3H pilot wells during the nine months
ended March 31, 2025.
34
Capital Commitments
We had the following five-year capital commitments as of the periods indicated (in thousands), which are not
recognized as liabilities or payables on the condensed consolidated balance sheet:
| Capital commitments: | March 31, 2025 | June 30, 2024 |
|---|---|---|
| Sweetpea | $21,972 | $23,283 |
| EP 161 | $2,500 | $2,650 |
| Beetaloo Joint Venture | $70,761 | $62,642 |
| Midstream | $4,956 | $1,972 |
Sweetpea
As of March 31, 2025, the Company’s wholly owned subsidiary, Sweetpea committed to spend $22.0 million
related to two licenses, EP 136 with total commitments of $13.3 million and EP 143 with total commitments of $8.7
million over the following five years.
A renewal application for EP 136 was submitted to the Department of Mining and Energy (“DME”) (formerly the
Department of Industry, Tourism and Trade) in September 2023, and approved in July 2024, granting a five-year extension
for the period July 24, 2025 to July 23, 2030 with a minimum work program commitment of $13.3 million.
A variation application for EP 143 was submitted to DME in August 2024, and approved in October 2024. The
total minimum work program commitments remain the same at $8.7 million with activity and associated spend being
transferred within the license term.
EP 161
For the EP 161 working interest, we are obligated to contribute our share of expenses to uphold our stake in this
permit, for which Santos Limited is the operator. Our commitment through March 2026 is approximately $2.5 million
based on the minimum work requirements. There are no minimum commitment requirements after March 2026.
Beetaloo Joint Venture
The terms of the Beetaloo Joint Venture necessitate specific minimum work obligations through May 2028. These
commitments include an expected spend of $70.8 million related to drilling and multi-stage hydraulic fracturing of four
wells, 2D seismic survey, and subsurface studies, with expenditure across EP 76 of $10.2 million, EP 98 of $49.6 million,
and EP 117 of $11.0 million. An application was submitted to DME on September 26, 2024 to vary the year 2 and 3 work
program, and is currently pending resolution.
Midstream
Committed spend for the SPCF project as of March 31, 2025, was $5.0 million which was related to the engineering,
procurement, and construction management for the detailed design, engineering, planning, construction, testing, inspection
and commissioning of the facility and major equipment procurement.
Other Commitments and Contingencies
On December 19, 2024, TR Ltd., as guarantor, entered into the Facility Agreement with TR West, as borrower,
each a wholly owned subsidiary of the Company, as obligors, and Macquarie, as lender. The Facility Agreement provides
TR West with Facility A amounting to A$25,000,000 in availability for performance bonds, and includes potential
additional Facility B and Facility C each amounting to A$5,000,000. Availability under the Facility B and Facility C is
subject, among other conditions, to the Company raising additional capital in the amounts of at least A$62,500,000 and
A$75,000,000, respectively. All Facilities terminate on December 19, 2027. The obligations under the Facility Agreement
are unconditionally guaranteed on a senior secured basis by TR Ltd.
35
As of March 31, 2025, there was A$7,684,129 of letters of credits issued under the Facility Agreement. As of
March 31, 2025 there was A$17,315,872 of unused credit under Facility A and A$10,000,000 of unused credit under
Facility B and Facility C.
36
Cash Flows
The following table summarizes our cash flows for the periods indicated (in thousands):
| Statement of Cash Flows: | Nine months ended March 31, 2025 | 2024 |
|---|---|---|
| Net cash used in operating activities | $(23,205) | $(10,494) |
| Net cash used in investing activities | (73,681) | (45,362) |
| Net cash from financing activities | 48,344 | 76,145 |
Net Cash Used in Operating Activities
For the nine months ended March 31, 2025, net cash used in operating activities was $23.2 million, during which
we incurred a net loss of $30.4 million, compared to net cash used in operating activities for the nine months ended
March 31, 2024 of $10.5 million, during which we incurred a net loss of $13.9 million. The net loss for the nine months
ended March 31, 2025, included the non-cash impacts of depreciation and amortization, stock-based compensation, loss on
remeasurement of assets classified as held for sale, accretion of asset retirement obligations, interest expense, checkerboard
fee and foreign exchange differences. Additionally, in the nine months ended March 31, 2025, net unfavorable changes in
operating assets and liabilities totaled $4.6 million, primarily consisting of a $3.9 million decrease in accounts payable and
accrued expenses due to timing of our pay cycle during the fiscal period, a $0.6 million increase in trade and other
receivables and a $0.2 million increase in prepaid expenses and other assets.
Net Cash Used in Investing Activities
For the nine months ended March 31, 2025, net cash used in investing activities was $73.7 million compared to
$45.4 million for the nine months ended March 31, 2024. In the period ended March 31, 2025, there was spend on
exploration and evaluation activities of $74.1 million in connection with the drilling of the SS2-H, SS-2H ST1 and SS-3H
pilot wells, expenditure of $11.5 million related to the detailed design and procurement of long lead items for the SPCF,
partially offset by proceeds from the sale of assets held for sale of $8.0 million for rig 403 and R&D tax credits of $6.2
million.
Net Cash from Financing Activities
For the nine months ended March 31, 2025, net cash received in financing activities was $48.3 million compared
to $76.1 million received for the nine months ended March 31, 2024. The decrease was primarily due proceeds from the
issuance of common stock of $73.1 millions that occurred in the comparative period, which didn't occur during the nine
months ended March 31, 2025, partially offset by the receipt of $7.4 million in gross proceeds from the greenshoe option
exercised in July 2024 and $48.5 million attributable to contributions from noncontrolling interest holders to fund their
share of cash calls.
Critical Accounting Estimates
Management’s discussion and analysis of our financial condition and results of operations are based upon our
condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of
our financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the
reported amounts of certain assets, liabilities and related disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses during the reporting period. The following critical
accounting policies relate to the more significant estimates and assumptions used in preparing the consolidated financial
statements.
The impact of, and any associated risks related to, estimates and assumptions are discussed within Management’s
Discussion and Analysis of Financial Condition and Results of Operations, as well as in the Notes to the Condensed
Consolidated Financial Statements, if applicable, where estimates and assumptions affect the Company’s reported and
expected financial results.
37
There have been no other material changes in critical accounting estimates at March 31, 2025 from those
described in the Company’s Annual Report on Form 10-K for the year ended June 30, 2024.
38
Controls and procedures
As filed, 4,262 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
As of March 31, 2025, our principal executive officer and principal financial officer concluded that we did
not maintain effective internal control over financial reporting due to the material weakness that was disclosed in our
Annual Report on Form 10-K for the year ended June 30, 2024.
As discussed in Part II, Item 9A, “Controls and Procedures” in our Annual Report on Form 10-K for the
year ended June 30, 2024, we identified the following deficiencies in our internal control over financial reporting,
which in the aggregate, constituted a material weakness:
i) lack of sufficient evidence retained of the performance of internal controls,
ii) insufficient resources in key accounting and finance roles leading to inadequate segregation of duties,
iii) lack of manage access and manage change IT general controls over the cloud-based enterprise resource
planning system, and
iv) accounting for complex transactions in accordance with U.S. GAAP.
Status of Remediation Efforts
In response to the material weakness identified and described above, our management, with the oversight of
the Audit & Risk Management Committee of our Board of Directors, will continue to dedicate significant efforts and
resources to further improve our control environment and to take steps to remediate this material weakness. As part
of our plan to address this material weakness, we are performing a full review, with the assistance of external
consultants, of our processes and internal controls. We have implemented a new enterprise resource planning system
to better support our financial reporting and internal control framework. We have implemented, and plan to continue
to implement, new controls and processes. We will also provide training to control owners, supported by external
consultants, as appropriate, in support of an effective internal control framework, including how to sufficiently
document and evidence the operation of internal controls. We have also hired a Vice President of Information
Technology and a Financial Reporting Manager with extensive knowledge in their respective fields to assist in the
remediation of the above control deficiencies. We will continue to hire accounting and finance personnel, or engage
technical specialists, who possess the required technical knowledge to ensure reporting requirements are met and
segregation of duties are maintained.
While we have begun implementing a plan to remediate this material weakness, we cannot predict the
success of such plan or the outcome of our assessment of this plan at this time. If our steps are insufficient to
successfully remediate the material weakness and otherwise establish and maintain an effective system of internal
control over financial reporting, the reliability of our financial reporting, investor confidence in us, and the value of
our common stock could be materially and adversely affected. We can give no assurance that the implementation of
this plan will remediate this deficiency in internal control or that additional material weaknesses in our internal
control over financial reporting will not be identified in the future. Our failure to implement and maintain effective
internal control over financial reporting could result in errors in our financial statements that could result in a
restatement of our financial statements, or cause us to fail to meet our periodic reporting obligations. For as long as
we are an “emerging growth company” under the JOBS Act, our independent registered public accounting firm will
not be required to attest to the effectiveness of our internal control over financial reporting pursuant to Section 404.
39
Changes in Internal Control Over Financial Reporting
Except for the implementation of our remediation plans in connection with our ineffective disclosure
controls and procedures described above, there were no changes in the Company’s internal control over financial
reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) during the quarter ended
March 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over
financial reporting.
40
Risk factors
As filed, 197 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes in risk factors for the quarterly period ended March 31, 2025 from those
described in the Company’s Annual Report on Form 10-K for the year ended June 30, 2024.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $0 | us-gaap:Revenues |
| Revenue | 9 months2024-07-01 to 2025-03-31 | $0 | us-gaap:Revenues |
| Research and development | 3 months2025-01-01 to 2025-03-31 | $2.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-07-01 to 2025-03-31 | $5.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2025-01-01 to 2025-03-31 | −$8.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-07-01 to 2025-03-31 | −$30.8m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2025-01-01 to 2025-03-31 | −$6.7m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-07-01 to 2025-03-31 | −$26.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | −$0.46 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-07-01 to 2025-03-31 | −$1.86 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | −$0.46 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-07-01 to 2025-03-31 | −$1.86 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 14,536,774 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-07-01 to 2025-03-31 | 14,336,033 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-07-01 to 2025-03-31 | −$23.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2025-03-31 | $25.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $37.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $381.5m | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $34.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $56.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2025-03-31 | $239.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-25-025261. Last ingested by Listed: Oct 30, 2026, 06:57 ET. Listed shows no prices and gives no investment advice.